Current position:Home >Product >
Benzoicacid,3,5-diethyl-4-(hexahydro-7,9-dioxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-8-yl)-
Benzoicacid,3,5-diethyl-4-(hexahydro-7,9-dioxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-8-yl)-(881376-42-7)
- Name: Benzoicacid,3,5-diethyl-4-(hexahydro-7,9-dioxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-8-yl)-
- Synonyms:Benzoicacid,3,5-diethyl-4-(hexahydro-7,9-dioxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-8-yl)-;4’Desmethyl-4’Carboxylate Pinoxaden Despivoloyl;Phenyl Acetate Impurity 44;Pinoxaden Metabolite SYN502836;Pinoxaden Metabolite -2
- Molecular Formula:C18H22N2O5
- Molecular Weight:346.38
- CAS Registry Number:881376-42-7
- EINECS:
- Melting Point:513.1±60.0 °C(Predicted)
- Water Solubility:
Other Product
- 881218-54-8/4-Butoxy-N-(4-phenyl-1,2,5-oxadiazol-3-yl)benzamide
- 881222-52-2/N-benzyl-2-(3-methylbutoxy)benzamide
- 881222-55-5/2-(3-methylbutoxy)-N-1,3-thiazol-2-ylbenzamide
- 881242-91-7/Acetic acid, 2-[(5-formylimidazo[2,1-b]thiazol-6-yl)thio]-, methyl ester
- 881249-07-6/1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-(4,6-diMethoxy-1,3,5-triazin-2-yl)hexahydro-2-oxo-, (3aS,4S,6aR)-
- 881282-85-5/881282-85-5
- 88128-61-4/1H-Benz[e]indene-3,7(2H,3aH)-dione, 4,5,8,9,9a,9b-hexahydro-3a-methyl-6-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]-, (3aS,9aS,9bS)-
- 881288-21-7/1-Naphthalenesulfonamide, 4-bromo-N-methyl-
- 88129-11-7/2-Pyrimidinamine, 1,6-dihydro-1-methyl-4-(4-methylphenyl)-6-phenyl-, hydriodide (1:1)
- 88129-13-9/2-Pyrimidinamine, 1,4,5,6-tetrahydro-1-methyl-4-(4-methylphenyl)-6-phenyl-, hydrochloride (1:1)
- 88129-25-3/3,6,9,12,20,23,26,29-Octaoxa-35,36-diazatricyclo[29.3.1.114,18]hexatriaconta-1(35),14,16,18(36),31,33-hexaene-2,13,19,30-tetrone
- 88129-75-3/α-D-Mannopyranosiduronic acid, methyl 2-O-methyl-, methyl ester
- 881300-32-9/3-Pyridinecarbonitrile, 6-(4-methoxyphenyl)-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-
- 881301-91-3/MFCD01029103
- 881302-41-6/3,4-dichloro-N-(2-hydroxyphenyl)benzenesulfonamide
- 881304-82-1/Boron, [1-deoxy-N-ethyl-1-[6-[[3-[[1-oxo-6-[[[4-[(1E)-2-[5-[[5-(2-thienyl)-2H-pyrrol-2-ylidene-κN]methyl]-1H-pyrrol-2-yl-κN]ethenyl]phenoxy]acetyl]amino]hexyl]amino]propyl]amino]-9H-purin-9-yl]-β-D-ribofuranuronamidato]difluoro-, (T-4)- (9CI)
- 88133-54-4/N-Cbz-DL-4-Amino-Phenylglycine
- 88135-26-6/methyl 2-(4-amino-2,6-dichlorophenyl)acetate
- 881373-72-4/1,4-BenzenediaMine, N-[2-(1-Methyl-1H-indol-3-yl)ethyl]-N,N'-di-4-pyridinyl-
- 881376-42-7/Benzoicacid,3,5-diethyl-4-(hexahydro-7,9-dioxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-8-yl)-
- 881389-82-8/1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-[[4-[(diMethylaMino)Methyl]phenyl]Methyl]hexahydro-2-oxo-, (3aS,4S,6aR)-
- 881391-76-0/3-Pyridazinecarboxamide, N-(2-cyclopropylethyl)-6-[4-[[2-(trifluoromethyl)phenoxy]methyl]-1-piperidinyl]-
- 881391-78-2/3-Pyridazinecarboxamide, N-(2-cyclopropylethyl)-6-[4-methyl-4-[2-(trifluoromethyl)phenoxy]-1-piperidinyl]-
- 881392-14-9/3H-Pyrrolo[1,2-b][1,2,4]triazole-7-carboxylic acid, 5-[[[bis(2-ethoxy-2-oxoethyl)amino]carbonyl]oxy]-6-cyano-2-[4-(1,1-dimethylethyl)phenyl]-, 2,6-bis(1,1-dimethylethyl)-4-methylcyclohexyl ester compd. with 2-propanol (1:1)
- 88140-37-8/β-D-Glucopyranoside, (3β,12β)-20-(β-D-glucopyranosyloxy)-12-hydroxydammar-24-en-3-yl 2-O-[6-O-(2-carboxyacetyl)-β-D-glucopyranosyl]-
- 881413-17-8/Ethanesulfonamide, N-[2-(1,1-dimethylethyl)-1-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-benzimidazol-5-yl]-N-methyl-
- 881413-62-3/Acetamide, N-[1-[(4,4-difluorocyclohexyl)methyl]-2-(1,1-dimethylethyl)-1H-benzimidazol-5-yl]-
- 881429-06-7/2-[5-(4-Chloro-phenyl)-1-methyl-1H-pyrrol-2-ylmethylene]-malononitrile
- 881432-54-8/3-(4-ethoxyanilino)-6-(4-methylphenyl)-2H-1,2,4-triazin-5-one
- 881432-57-1/3-(3,4-dimethylanilino)-6-(4-methylphenyl)-2H-1,2,4-triazin-5-one